Advances in RNA-based nanotherapies for arthritis

Christine T.N. Pham; Farshid Guilak

doi:10.1038/s41584-025-01339-1

Advances in RNA-based nanotherapies for arthritis

Research output: Contribution to journal › Review article › peer-review

Abstract

Many of the current therapies for arthritis lack a targeted approach, limiting clinical benefits. Nanoparticle-based delivery systems have enabled more precise and efficient delivery of therapeutic agents, particularly nucleic acids. Studies in 2025 emphasize the promise of these strategies for the treatment of various forms of arthritis.

Original language	English
Pages (from-to)	80-81
Number of pages	2
Journal	Nature Reviews Rheumatology
Volume	22
Issue number	2
DOIs	https://doi.org/10.1038/s41584-025-01339-1
State	Published - Feb 2026

Access to Document

10.1038/s41584-025-01339-1

Cite this

@article{28e1dba608fb420aaa0e6ed3825f6795,

title = "Advances in RNA-based nanotherapies for arthritis",

abstract = "Many of the current therapies for arthritis lack a targeted approach, limiting clinical benefits. Nanoparticle-based delivery systems have enabled more precise and efficient delivery of therapeutic agents, particularly nucleic acids. Studies in 2025 emphasize the promise of these strategies for the treatment of various forms of arthritis.",

author = "Pham, \{Christine T.N.\} and Farshid Guilak",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2025.",

year = "2026",

month = feb,

doi = "10.1038/s41584-025-01339-1",

language = "English",

volume = "22",

pages = "80--81",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

number = "2",

}

TY - JOUR

T1 - Advances in RNA-based nanotherapies for arthritis

AU - Pham, Christine T.N.

AU - Guilak, Farshid

N1 - Publisher Copyright: © Springer Nature Limited 2025.

PY - 2026/2

Y1 - 2026/2

N2 - Many of the current therapies for arthritis lack a targeted approach, limiting clinical benefits. Nanoparticle-based delivery systems have enabled more precise and efficient delivery of therapeutic agents, particularly nucleic acids. Studies in 2025 emphasize the promise of these strategies for the treatment of various forms of arthritis.

AB - Many of the current therapies for arthritis lack a targeted approach, limiting clinical benefits. Nanoparticle-based delivery systems have enabled more precise and efficient delivery of therapeutic agents, particularly nucleic acids. Studies in 2025 emphasize the promise of these strategies for the treatment of various forms of arthritis.

UR - https://www.scopus.com/pages/publications/105023698622

U2 - 10.1038/s41584-025-01339-1

DO - 10.1038/s41584-025-01339-1

M3 - Review article

C2 - 41326633

AN - SCOPUS:105023698622

SN - 1759-4790

VL - 22

SP - 80

EP - 81

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 2

ER -

Advances in RNA-based nanotherapies for arthritis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this